Accuryn

Sepsis is the second highest cause of maternal death in India.

Sepsis is the body’s drastic response to an extreme infection, with symptoms ranging from fever and tissue damage to organ failure and death.

The threat of Sepsis is particularly grave in India, with a mortality rate of 42% in Critical Care patients who contract an infection. (1)

IndianFile

 Early diagnosis of Sepsis can save both lives and costs

Delays in diagnosis can be fatal: Studies show that mortality from septic shock increased by 7.6% with every hour that treatment was delayed

The estimated economic impact of earlier detection and treatment is significant:

  • 92,000 fewer deaths annually (2)
  • 1.25 million less hospital days annually (2)
  • Hospital expenditure reduction of over $1.5 billion (2)

 

delay-in-diagnosis3

 

 Accuryn™ is designed for ICU’s in the developing world

The Accuryn™ catheter is comprised of a twofold medical system: the Accuryn™ computational and display device, and the patented Accuryn™ Urimeter.

 

Accuryn-Tech-2

 

By utilizing the urine drainage catheter, already found in most ICU patients, the Accuryn™ catheter can help with early detection of sepsis as well as extract a significant amount of valuable clinical data.

Accuryn-Tech-with-words

 

The Accuryn™ Urimeter uses proprietary airlock-prevention technology to overcome urine drainage issues present in other catheters. Thus allowing for accurate, and continuous urine output measurement as well as decreased urinary retention and suction trauma – both of which are known risk factors for Catheter associated urinary Tract Infections (CAUTI)

 

The Accuryn™ is also capable of connecting wirelessly to Medical providers smartphones or computer systems. Allowing doctors to know their patients medical conditions at all times, and receive updates of any sudden changes.

 

Connection

 

The high volume of available data and efficient data transfer makes Accuryn™ an ideal stand-alone critical care monitor for the developing world.

LEARN MORE: Clinical Trials of Accuryn™

 

1.  Deb Roy, Sumitra, “1 in 4 ICU patients gets sepsis, 1 in 2 dies” , The Times of India, 2012 Sep 12; http://timesofindia.indiatimes.com/india/1-in-4-ICU-patients-gets-sepsis-1-in-2-dies/articleshow/16360235.cms

2. Meddings, J, et al, “Impact of Non-Payment for Hospital-Acquired Catheter-Associated Urinary Tract Infection: A Statewide Analysis”, Ann Intern Med. 2012 Sep 4; 157(5): 305–312